Unknown OBSERVATIONAL NCT06137612

Spinal Cord Gray Matter Imaging in Spinal Muscular Atrophy

Spinal Cord Gray Matter Imaging - a Novel Biomarker for Spinal Muscular Atrophy - a Pilot Study

Sponsor: University Hospital, Basel, Switzerland

Conditions Spinal Muscular Atrophy Type II Spinal Muscular Atrophy Type III

Interventions MRI

Updated 4 times since 2023 Last updated: Nov 15, 2023 Started: Aug 17, 2020 Primary completion: Dec 31, 2024 Completion: Sep 15, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06137612, this observational or N/A phase trial focuses on Spinal Muscular Atrophy Type II and Spinal Muscular Atrophy Type III and remains ongoing. Sponsored by University Hospital, Basel, Switzerland, it has been updated 4 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Jan 2026 — Present [monthly]

Unknown

Status: Enrolling By Invitation → Unknown
Sep 2024 — Jan 2026 [monthly]

Enrolling By Invitation
Jul 2024 — Sep 2024 [monthly]

Enrolling By Invitation
Dec 2023 — Jul 2024 [monthly]

Enrolling By Invitation

First recorded

Aug 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Basel, Switzerland

Data source: University Hospital, Basel, Switzerland

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Basel, Switzerland